Lexeo Therapeutics issues $3 million in unregistered shares in Mantle merger
LXEO•Lexeo issued $3 million of common stock in an unregistered sale tied to its merger with Mantle, alongside $5.3 million in upfront cash, subject to adjustments.
1. Merger consideration
Lexeo issued the shares at the merger’s effective time under exemptions from registration under Securities Act Section 4(a)(2) and/or Regulation D. The transaction also included $5.3 million in upfront cash, subject to adjustments.
